Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 September 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 189 pages)

 

Export 5 results:
Author Title [ Type(Desc)] Year
Filters: Author is Sarsour, K.  [Clear All Filters]
Journal Article
J. C. Wilson, Sarsour, K., Gale, S., Petho-Schramm, A., Jick, S. S., and Meier, C. R., Incidence and risk of glucocorticoid-associated adverse effects in patients with rheumatoid arthritis, Arthritis Care Res (Hoboken), 2018.
H. Petri, Nevitt, A., Sarsour, K., Napalkov, P., and Collinson, N., Incidence of giant cell arteritis and characteristics of patients: data-driven analysis of comorbidities, Arthritis Care Res (Hoboken), vol. 67, pp. 390-5, 2015.
J. C. Wilson, Sarsour, K., Collinson, N., Tuckwell, K., Musselman, D., Klearman, M., Napalkov, P., Jick, S. S., Stone, J. H., and Meier, C. R., Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis, Semin Arthritis Rheum, vol. 46, pp. 650-656, 2017.
S. Gale, Wilson, J. C., Chia, J., Trinh, H., Tuckwell, K., Collinson, N., Dimonaco, S., Jick, S., Meier, C., Mohan, S. V., and Sarsour, K., Risk Associated with Cumulative Oral Glucocorticoid Use in Patients with Giant Cell Arteritis in Real-World Databases from the USA and UK, Rheumatol Ther, 2018.
J. C. Wilson, Sarsour, K., Collinson, N., Tuckwell, K., Musselman, D., Klearman, M., Napalkov, P., Jick, S. S., Stone, J. H., and Meier, C. R., Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis, Semin Arthritis Rheum, vol. 46, pp. 819-827, 2017.
[Page last reviewed 6 September 2019]